On 16 May, we hosted ‘Making an Impact’, a continuation of our series of educational events designed to highlight and showcase the latest in blood cancer research, technologies and next-generation treatments. In 2024, the event was focused specifically on myeloma; a type of blood cancer that has gained a lot of media attention lately, due … Continued
Gillian has always led a life filled with purpose and passion. From her early days as a school teacher to her 25-year stint in the publishing business, she has never shied away from taking on new challenges. But it was a deeply personal tragedy that truly defined her philanthropic journey and inspired her to leave … Continued
Geoff Nyssen, a devoted husband and father of two, has faced a decade-long journey with blood cancer. Diagnosed with multiple myeloma in 2014 at the age of 40, Geoff faced an uphill journey full of uncertainty and challenges. Over the years, Geoff has undergone a myriad of treatments, each presenting its own set of challenges. … Continued
Tahli’s life took an unexpected turn in the autumn of 2020. A busy mother of two and a talented baker, she found herself facing a daunting diagnosis: stage 4 lymphoma. As she navigated her journey from diagnosis to treatment and ultimately remission, Tahli’s story became one of hope and advocacy for groundbreaking medical treatments like … Continued
We recently sat down with Snowdome Board Director, Helen Buckingham OAM, to get her thoughts on the funding of a new immunotherapy treatment for myeloma, and how clinicians and patients can have their say.
1949 – 2022. On 7 September 2022, Snowdome lost a much loved and admired member of our family, Dr John Tandy. John is the father of co-founder Rob Tandy, and his diagnosis of multiple myeloma in 2009 was the catalyst and part of the first chapter in the Snowdome story. Our vision is bound together … Continued
In laboratories around the country and the world, Australian researchers and clinicians are striving to find new blood cancer treatments to make it a curable disease for all. We are proud to support one such researcher, Queensland’s clinician scientist, Dr Siok Tey, who is recognised nationally and internationally for her work in bone marrow transplantation … Continued
Immunotherapy is a bright beacon of hope in the quest for better cancer treatments. CAR-T cell therapy, a form of immunotherapy created through modifying a person’s own T-cells to identify and destroy cancer cells, shows significant promise for patients, clinicians and researchers alike. Yet not all those who receive CAR-T cell treatment respond, and some … Continued
CAR-T cell therapy, a form of immunotherapy, is delivering great hope in the treatment of blood cancers. We are proud to support Dr Katherine Cummins, a Haematologist and Clinician Scientist, in her research project investigating immunotherapy as a treatment for acute myeloid leukaemia. Dr Cummins is our 2022 Gunn Family Women in Haematology Fellow, which … Continued